14 days ago
INSM
AnalystsJessica FyeJessica Fye's Stock Forecasts
AnalystsJessica Fye
Analyst Ranking
Top 10%
#469 out of 4755 analysts
Average Return
+13.59%
Win Rate
57%56 out of 99
Risk vs Reward
Poor
Good
Jessica Fye's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Rayzebio IncRYZB | +212.45% | $20.00 | $62.49 | 2023-10-09 - 2024-02-23 | Strong Buy |
Insmed IncINSM | +199.43% | $24.62 | $73.72 | 2023-11-19 - 2024-11-19 | Strong Buy |
Stemline Therapeutics IncSTML | +178.35% | $4.25 | $11.83 | 2020-03-25 - 2020-06-10 | Strong Buy |
Ascendis Pharma AASND | +134.77% | $27.90 | $65.50 | 2017-05-10 - 2018-05-11 | Strong Buy |
Crinetics Pharmaceuticals IncCRNX | +82.56% | $30.22 | $55.17 | 2023-11-19 - 2024-11-19 | Strong Buy |
Jessica Fye Analyst Color
Get additional color on Jessica Fye's coverage of popular stocks
a month ago
ITCI
a month ago
BGNE
3 months ago
BMRN
4 months ago
ASND
4 months ago
BGNE
4 months ago
JAZZ
5 months ago
DNLI
6 months ago
INSM
6 months ago
MIRM
6 months ago
INSM
2 years ago
ITCI
2 years ago
LEGN
2 years ago
LEGN
2 years ago
VRTX
2 years ago
MRNA
2 years ago
IMCR
3 years ago
UTHR
3 years ago
CARA
Jessica Fye's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Moderna IncMRNA | 11 | Strong Sell | $45.00 | +4.80% | Maintains | 10 days ago |
Biontech SeBNTX | 10 | Hold | $122.00 | +2.66% | Maintains | 10 days ago |
Insmed IncINSM | 6 | Strong Buy | $83.00 | +10.18% | Maintains | 14 days ago |
Vertex Pharmaceuticals IncVRTX | 6 | Strong Buy | $503.00 | +9.37% | Maintains | a month ago |
Intra Cellular Therapies IncITCI | 6 | Strong Buy | $89.00 | +5.84% | Maintains | a month ago |
Biomarin Pharmaceutical IncBMRN | 3 | Strong Buy | $109.00 | +64.75% | Maintains | a month ago |
Incyte CorpINCY | 5 | Hold | $71.00 | -5.23% | Maintains | a month ago |
Alkermes PLCALKS | 6 | Hold | $26.00 | -16.64% | Maintains | a month ago |
Ascendis Pharma AASND | 6 | Strong Buy | $174.00 | +31.75% | Maintains | a month ago |
Beigene LtdBGNE | 4 | Strong Buy | $235.00 | +16.53% | Maintains | a month ago |
Denali Therapeutics IncDNLI | 4 | Strong Buy | $28.00 | +20.07% | Maintains | 2 months ago |
Mbx Biosciences IncMBX | 1 | Strong Buy | $30.00 | +55.52% | Initiates Coverage On | 2 months ago |
Halozyme Therapeutics IncHALO | 5 | Hold | $57.00 | +18.60% | Downgrades | 3 months ago |
Ionis Pharmaceuticals IncIONS | 2 | Hold | $55.00 | +49.66% | Maintains | 3 months ago |
Alnylam Pharmaceuticals IncALNY | 3 | Hold | $280.00 | +11.19% | Maintains | 3 months ago |
Jazz Pharmaceuticals PLCJAZZ | 3 | Strong Buy | $202.00 | +64.04% | Maintains | 4 months ago |
Immunocore Holdings PLCIMCR | 4 | Strong Buy | $66.00 | +113.11% | Maintains | 5 months ago |
Crinetics Pharmaceuticals IncCRNX | 3 | Strong Buy | $54.00 | -6.40% | Maintains | 5 months ago |
Mirum Pharmaceuticals IncMIRM | 3 | Strong Buy | $39.00 | -12.16% | Maintains | 6 months ago |
United Therapeutics CorpUTHR | 6 | Strong Buy | $300.00 | -19.87% | Maintains | 7 months ago |
Stoke Therapeutics IncSTOK | 2 | Hold | $13.00 | +3.42% | Maintains | 8 months ago |
Deciphera Pharmaceuticals IncDCPH | 4 | Hold | $16.00 | -37.48% | Maintains | 9 months ago |
Novocure LtdNVCR | 3 | Hold | $17.00 | -36.09% | Maintains | 9 months ago |
Cerevel Therapeutics Holdings IncCERE | 4 | Hold | $45.00 | +0.09% | Maintains | a year ago |
Karuna Therapeutics IncKRTX | 1 | Hold | $330.00 | +0.05% | Downgrades | a year ago |
Biocryst Pharmaceuticals IncBCRX | 2 | Strong Buy | $10.00 | N/A | Reinstates | a year ago |
Rayzebio IncRYZB | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | a year ago |
Legend Biotech CorpLEGN | 2 | Strong Buy | $76.00 | N/A | Maintains | 2 years ago |
Emergent Biosolutions IncEBS | 1 | Strong Sell | $9.00 | N/A | Downgrades | 2 years ago |
Esperion Therapeutics IncESPR | 5 | Hold | $9.00 | N/A | Maintains | 2 years ago |
Seagen IncSGEN | 2 | Strong Buy | $150.00 | N/A | Maintains | 2 years ago |
Tricida IncTCDAQ | 2 | Strong Sell | N/A | N/A | Downgrades | 2 years ago |
Nektar TherapeuticsNKTR | 2 | Strong Sell | N/A | N/A | Downgrades | 2 years ago |
Amarin Corp PLCAMRN | 1 | Strong Sell | N/A | N/A | Downgrades | 3 years ago |
Cara Therapeutics IncCARA | 2 | Strong Buy | $20.00 | N/A | Upgrades | 3 years ago |
Landos Biopharma IncLABP | 2 | Hold | $70.00 | N/A | Maintains | 3 years ago |
Dianthus Therapeutics IncDNTH | 1 | Hold | $7.00 | N/A | Downgrades | 3 years ago |
Lava Therapeutics NvLVTX | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | 4 years ago |
Aptinyx IncAPTX | 1 | Strong Sell | N/A | N/A | Downgrades | 4 years ago |
Lexicon Pharmaceuticals IncLXRX | 1 | Hold | $7.00 | N/A | Upgrades | 4 years ago |
Stemline Therapeutics IncSTML | 2 | Strong Buy | $8.00 | N/A | Maintains | 5 years ago |
Arena Pharmaceuticals IncARNA | 1 | Strong Buy | $58.00 | N/A | Upgrades | 5 years ago |
Axcella Health IncAXLA | 2 | Strong Buy | $275.00 | N/A | Maintains | 5 years ago |
Aprea Therapeutics IncAPRE | 1 | Hold | $460.00 | N/A | Initiates Coverage On | 5 years ago |
Mersana Therapeutics IncMRSN | 4 | Strong Sell | N/A | N/A | Downgrades | 6 years ago |
Amag Pharmaceuticals IncAMAG | 1 | Strong Sell | $18.00 | N/A | Downgrades | 6 years ago |
Radius Health IncRDUS1 | 4 | Strong Buy | $52.00 | N/A | Maintains | 6 years ago |
Chimerix IncCMRX | 1 | Strong Sell | N/A | N/A | Downgrades | 7 years ago |
Enanta Pharmaceuticals IncENTA | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Advanced Accelerator Applications SaAAAP | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.